About Veracyte
Our molecular tests provide important information that helps doctors make key decisions that can change the course of each cancer patient’s care and improve outcomes.

Our molecular tests provide important information that helps doctors make key decisions that can change the course of each cancer patient’s care and improve outcomes.
At every stage, clinicians and patients face difficult decisions – often with limited information.
With our molecular tests for thyroid, prostate, breast, bladder, and lung cancer, clinicians have access to biological insights that help inform more personalized and effective care.
Veracyte is a global cancer diagnostics company. Our molecular tests assess the unique biology of each patient’s tumor to help clinicians answer essential questions about cancer care.
Can the patient avoid unnecessary surgery?
Can the patient be monitored rather than begin treatment immediately?
What treatment will be most effective for the patient’s specific cancer?
Is the treatment providing the intended benefit?
OUR MISSION
Transform cancer care for patients all over the world
We seek a better way
We pursue bold ideas, embrace complexity, and keep pushing forward.
We make it happen
We act with urgency, deliver with excellence, and always find a way.
We are stronger together
We engage with empathy, align around what’s best for Veracyte, and celebrate as one team.
We care deeply
We show up with integrity, kindness, and respect for one another.
Our team leading cancer diagnostic innovation.
Discover rewarding career opportunities with us.
View scientific publications, videos, FAQS, and more.
Inspiring stories and latest clinical advances.